Abstract:The looming threat of antibiotic‐resistant bacteria is one of the major challenges of the 21st century across clinical, agricultural, and environmental domains. Despite this crisis, the antibiotic discovery has stagnated, emphasizing the urgent need to explore yet overlooked ecological niches teeming with microbial competition. For istance, by targeting 'microbial oases of interaction', such as the plant rhizosphere, biological soil crust, deep‐sea and the more recent plastisphere, there is potential to uncover novel antibiotics. This approach represents a critical aspect of microbial ecology and evolution, offering a promising avenue in the battle against antibiotic resistance. In the relentless battle for human health, the proliferation of antibiotic‐resistant bacteria has emerged as an impending catastrophe of unprecedented magnitude, potentially driving humanity towards the brink of an unparalleled healthcare crisis. The unyielding advance of antibiotic resistance looms as the foremost threat of the 21st century in clinical, agricultural and environmental arenas. Antibiotic resistance is projected to be the genesis of the next global pandemic, with grim estimations of tens of millions of lives lost annually by 2050. Amidst this impending calamity, our capacity to unearth novel antibiotics has languished, with the past four decades marred by a disheartening 'antibiotic discovery void'. With nearly 80% of our current antibiotics originating from natural or semi‐synthetic sources, our responsibility is to cast our investigative nets into uncharted ecological niches teeming with microbial strife, the so‐called 'microbial oases of interactions'. Within these oases of interactions, where microorganisms intensively compete for space and nutrients, a dynamic and ever‐evolving microbial 'arms race' is constantly in place. Such a continuous cycle of adaptation and counter‐adaptation is a fundamental aspect of microbial ecology and evolution, as well as the secrets to unique, undiscovered antibiotics, our last bastion against the relentless tide of resistance. In this context, it is imperative to invest in research to explore the competitive realms, like the plant rhizosphere, biological soil crusts, deep sea hydrothermal vents, marine snow and the most modern plastisphere, in which competitive interactions are at the base of the microorganisms' struggle for survival and dominance in their ecosystems: identify novel antibiotic by targeting microbial oases of interactions could represent a 'missing piece of the puzzle' in our fight against antibiotic resistance.

The “Three Cs” of Novel Antibiotic Discovery and Production through Synthetic Biology: Biosynthetic Gene Clusters, Heterologous Chassis, and Synthetic Microbial Consortia

Combinatorial biosynthesis of novel aminoglycoside antibiotics via pathway engineering

Synthetic Biology Tools for Engineering Microbial Cells to Fight Superbugs

The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies

Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research

Natural antibiotics against antimicrobial resistance: sources and bioinspired delivery systems

Bacterial synthetic biology: tools for novel drug discovery

Bacterial Natural Product Drug Discovery for New Antibiotics: Strategies for Tackling the Problem of Antibiotic Resistance by Efficient Bioprospecting

Natural Products Resolve Antibiotic Resistance Crisis

Antimicrobials from endophytes as novel therapeutics to counter drug-resistant pathogens

Genome mining and prospects for antibiotic discovery

Multiplexing bacteriocin synthesis to kill and prevent antimicrobial resistance

Alternative natural sources for a new generation of antibacterial agents

Using bacterial genomes and essential genes for the development of new antibiotics

Three Innovations of Next-Generation Antibiotics: Evolvability, Specificity, and Non-Immunogenicity

The antibiotic crisis: On the search for novel antibiotics and resistance mechanisms

The Science of Antibiotic Discovery

Antibiotic dialogues: induction of silent biosynthetic gene clusters by exogenous small molecules

Biosynthesis of C-nucleoside antibiotics in actinobacteria: recent advances and future developments

Harnessing biotechnology for penicillin production: Opportunities and environmental considerations

Towards the sustainable discovery and development of new antibiotics